Using an in vitro assay we assessed whether the acute exposure of soleus muscle of adult and aged rats to essential amino acid enriched mixture (EAAem) activates mTOR signaling pathway (mTOR and p70S6K) even after prolonged supplementation with the same mixture. A total of 20 adult (9 months of age at the end of treatment) and 20 aged (18 months of age at the end of treatment) male Wistar rats were used. Ten of each group were treated with EAAem (1.5 gr/kglday in tap water) for 6 months. At the end of treatment the rats were grouped (n = 5 each group) as follows: adult (AD) and aged (AG) untreated controls; adult (AD_EAAem) and aged (AG_EAAem) chronically supplemented with EAAem; adult (AD+EAAem) and aged (AG+EAAem) acutely incubated with EAAem (soleus in 1% EAAem for 30 min); AD_EAAem+ and AG_EAAem+ acutely incubated with EAAem. Following treatment the activation level of mTOR and p70S6K was measured by Western blot. The basal level of mTOR and p70S6K activation appeared to be higher in AD compared with AG. In AG+EAAem a significant change in the level ofp70S6K activation, unlike mTOR, was observed whereas no change was observed in AD+EAAem. In AD_EAAem muscles the basal level of p70S6K activation, unlike mTOR, was significantly lower than in AD and the acute exposure to EAAem produced a significant reduction of mTOR activation. Contrarily to AG, in AG_EAAem+ the acute exposure to EAAem produced a significant activation of mTOR, unlike p70S6K. Results in the adults indicated a higher basal level of activation and a lower responsiveness of the pathway to acute and chronic exposure to EAA-enriched mixture. On the contrary, in the aged, a lower basal level of activation was associated with a higher responsiveness to EAAem. In particular, although with a different timing, acute exposure to EAAem activated mTOR signaling even following prolonged supplementation.
the change in whole-body protein turnover reflects a decreased synthesis rate rather than an increased catabolic rate (3) . Indeed, research has consistently reported that the rate of muscle protein synthesis is lower in older adults when compared to younger adults (2, (4) (5) (6) .
Mechanical load to the muscle, injury and nutritional interventions are the most powerful and effective stimuli underlying protein synthesis both in the young and in the elderly (I). However, the subsequent hypertrophic response appears to be smaller with age (7) (8) (9) (10) .
The mammalian target of rapamycin (mTOR) kinase leads a fundamental signaling pathway controlling protein synthesis and is now recognized as a key regulator of cell growth and a pivotal sensor of the nutritional status over the lifespan (11) .
Studies on animal models and humans showed that essential amino acids (EAA) unlike non-EAAs (12, 13) , are fundamental regulators of protein synthesis and mitochondrial biogenesis (14) throughout life (15) (16) . Among EAAs, branched chain amino acids (BCAA: leucine, isoleucine and valine) play a very important role as nutrient signals regulating muscle protein synthesis through the stimulation of insulin-independent and rapamycin-sensitive (mTOR) pathways (17, 18) . In particular, available data suggest that at least part of the postprandial translational activation is to be attributed to BCAAs through the activation of mTOR and downstream effectors (eIF4G, S6Kl and 4E-BPI).
Thus the scenario arising from available studies indicates that the physiological anabolic response to EAA may help in counteracting the metabolic unbalance induced by ageing, but it is currently unknown whether the effects on protein signaling activation are blunted by prolonged EAA supplementation.
In this study an in vitro assay was used to investigate whether the acute exposure of skeletal muscle to EAA-enriched mixture (EAAem) is effective in promoting the activation of mTOR signaling even following prolonged supplementation in adult and aged rats.
The results demonstrated that, although with a different timing, acute exposure to EAAem activates mTOR signaling in skeletal muscle of chronically treated elderly rats. Our data support the notion that mTOR pathway is a candidate target of EAA supplementation in chronic settings of supplementation.
MATERIALS AND METHODS

Animal treatment
The study was carried out on adult (9 months of age at the end of treatment, n=20) and aged (18 months of age at the end of treatment, n=20) male Wistar rats which were treated according to the ED guidelines and with the approval of the Institutional Ethics Committee. Animals were maintained in a 12/12 h light-dark cycle (7 a.m.-7 p.m.) and given unrestricted access to a standard diet (4.3 kcal % fat, 18.8 kcal % protein, 76.9 kcal % carbohydrate, Laboratorio Dottori Piccioni) and tap water. Ten rats of each group were treated with 1.5 gr/kg/day of EAAem (composition: 31.25% leucine, 16.25% lysine, 15.52% valine, 15.52% isoleucine, 8.75% threonine, 3.75% cysteine, 3.75% histidine, 2.6% phenylalanine, 1.25% methionine, 0.75% tyrosine, 0.5% tryptophan) in tap water for 6 months starting from 3 and 12 months of age respectively. The amino acid mixture was dissolved by calculating average daily drinking 2 weeks before the beginning of treatment (average drinking volumes: AD: 8.5±lml/100gr; AG: 9±2ml/100gr) and stored at 4°C before daily administration. Weekly checks of daily drinking volumes were made and no statistical difference was found between the start and end of treatment among groups (data not shown). At the end of treatment the rats were grouped (n=5 each group) as follows: AD adults controls; AG, aged controls; AD_EAAem, AD supplemented with EAAem; AG_EAAem, AG supplemented with EAAem; AD+EAAem untreated AD incubated with EAAem and AG+EAAem untreated AG incubated with EAAem; AD_EAAem+ incubated with EAAem; AG_EAAem+ incubated with EAAem.
At the end ofthe experimental period rats were starved for five hours and subsequently sacrificed by decapitation under ether anaesthesia and soleus muscle of the left leg was carefully dissected under a stereomicroscope.
Incubation procedure
On the day of sacrifice intact soleus muscles were preincubated with 50ml/ muscle Following preincubation the muscles were then incubated with 1% EAAem in Krebs solution (composition: NaCI 120 mM, KCI2.4 mM, CaCI2 2.5 mM, MgS04 1.2 mM, Glucose Ig/L, KH2P04 1.2 mM, NaHC03 24.8 mM, pH 7.4) for 30 min. These incubation parameters were shown to determine the highest cellular response to EAAem exposure in cell culture (13) . At the end of incubation, tissues were blotted on filter paper and immediately frozen in fluid nitrogen and stored at -80°C for subsequent analysis of signals (see below).
All incubations were performed at room temperature in medium continuously bubbled with 95% 02-5% C02 mixture.
Signaling pathway analysis by Western blot
The level of activation of mTOR and downstream target p70S6K in soleus muscles was investigated by Western blotting. The antibodies directed against p-mTOR (Ser2448) and p-p70S6K (Thr389) were obtained from Cell Signaling Technology (Danvers, MA, USA); anti-p70S6K was obtained from Upstate (Charlottesville, VA, USA), anti-mTOR was obtained from Sigma-Aldrich (Milano, Italy). Tissues were homogenized in lysis buffer (50 mM Tris.Cl pH 7.6,1 % Triton X 100, 150 mM NaCl, 5 mM EDTA, 100 mM NaF, 2 mM NaPPi, 2 mM Na3V04, 1 mM PMSF and I0 ug/ml, each of leupetin, pepstatin, aprotinin) using a Dounce Tissue Grinder (Wheaton, Millville, NJ, USA). The homogenate was centrifuged at 16,000 rpm, the supernatant was recovered and assayed for protein concentration by the Bradford Assay (Bio-Rad Laboratories, Milano, Italy). One hundred micrograms of protein extracts were run on a 7.5% SDS-PAGE formTOR, p-mTOR or 15% SDS-PAGE for p70S6K and p-p70S6K and transferred on a PVDF membrane (Millipore, Milano, Italy). The membranes were stained with Ponceau Red (Sigma-Aldrich, Milano, Italy) to verify the protein transfer and were blocked at RT for 2 h with 10% non-fat dry milk in TBST containing 0.1% Tween20. Thereafter, the blots were washed briefly and incubated with primary antibodies directed either against p70S6K and p-p70S6Kl (1:1000 OIN at 4°C), mTOR (1:3000 for 2 h at RT), p-m'Ior (1 :1000 OIN at 4°C diluted with 5% non-fat milk or 5% BSA (only for the phospho-specific antibodies) in TBST 0.1% Tween20. The membranes were washed 3 times for 10 min with TBST. Then they were incubated for 1 h at room temperature with anti-rabbit or anti-mouse (depending on the primary antibody) HRP-conjugated secondary antibody (Bio-Rad Laboratories, Milano, Italy) diluted 1/2000 in TBST containing 5% non-fat milk. The membranes were washed 3 times for 10 min, incubated in SuperSignal West Pico (Pierce Biotechnology, Rockford, IL, USA) chemiluminescent substrate and exposed to autoradiograph films (Fuji Photo Film Co., Dusseldorf, Germany). Optical densities of blot bands were finally determined by means of a computer-assisted densitometer. Results are expressed as phospho signal/total signal.
Statistical analysis
Data were expressed as means ± S.D. Statistical significance of the differences between means was assessed by one-way ANOVA followed by Student-Newman-Keuls test. A probability of less than 5% was considered significant (p<O.05).
RESULTS
Physiological parameters at the end of treatment are reported in Table I . A significant reduction of body weight was observed in AD_EAAem and AG_EAAem in comparison with AD and AG whereas no difference was observed in water and food consumption and absolute weight of soleus muscle. Interestingly when muscle weights were expressed as relative values to body weights, EAAem supplementation was associated with higher ratios (P < 0.05), suggesting a lowering of the body fat percentage and/or free fluid percentage following treatment in both groups of rats (Table I) .
The ratio between total and phosporylated mTOR (Ser2448) and p70S6K (Thr389) signal obtained in soleus from differently treated groups of rats is reported in Figs. I and 2 respectively. In untreated rats the basal level of mTOR and p70S6K phosphorylation appeared to be higher inAD (mTOR + 105%; p70S6K + 102%) compared with AG (Figs. I, 2). Following acute incubation with EAAm in AD muscle, neither signal showed significant change of activation (AD+EAAem). On the contrary, following acute exposure ofAG muscles, a significant increase of p70S6K activation unlike mTOR was observed (Fig. 2) . In AD EAAem muscles the basal level of p70S6K, unlike mTOR activation, appeared to significantly decrease (-95%) whereas an opposite variation was observed in AG EAAem muscles which showed an increased level of basal activation ofp70S6K, unlike mTOR.
Finally the acute exposure of chronically treated adult rats (AD_EAAem+) produced a significant reduction of the mTOR activation. On the contrary, a significant activation ofmTOR was observed in AG_ EAAem+ acutely exposed to EAAem, suggesting a different timing of activation compared to muscles from AG (Figs. 1 and 2) .
DISCUSSION
By using an in vitro assay we examined the effects of acute exposure to essential amino acid enriched mixture (EAAem) on the level of mTOR signaling activation in soleus muscle of adult (9 months) and aged (18 months) rats supplemented or not with the same mixture for six months (AD_EAAem and AG_ EAAem).
The results showed that: i) the basal level of mTOR and p70S6K activation was higher in AD compared to AG; ii) the acute exposure to EAAem of untreated muscles produced a significant change in the level ofp70S6K activation unlike mTOR only in AG; iii) after prolonged treatment (AD_EAAem) the basal level of p70S6K activation unlike mTOR decreased in the adult; iv) in AD_EAAem+ the acute exposure to EAAem produced a significant reduction of mTOR activation whereas in AG EAAem+ the same exposure produced activated mTOR unlike p70S6K.
As known, the capability ofthe mRNA translation system to fully respond to physiological stimuli as mechanical load and nutrients appears to be impaired in ageing (I). In particular, the aged muscle becomes resistant to the stimulatory effect of EAA at their physiological concentration range through reduced responsiveness of the metabolic pathways enrolled in translation of the mRNAs encoding for essential components of the protein synthetic machinery (10) . In old rats the sensitivity of muscle protein synthesis to EAA is lower than in adults and this is paralleled by their lesser ability to stimulate the mTOR rapamycin-sensitive pathway (19) . Indeed, an increase of EAA above postprandial levels has been associated with improved protein synthesis (19, 20) .
The amino acid supplement used in the present study was a leucine-(30%), isoleucine-, valine-, enriched mixture that has been found to improve age-related muscle disorders in rodents and humans (21, 22) and for which the mTOR/p70S6K pathway is identified as a putative signal pathway (14) , as previously demonstrated in the same experimental conditions in the rat (23) .
In ageing, the decreased anabolic response to EAA suggests that the signaling pathway carrying the amino acids signal is reduced and/or delayed compared to the young. Nevertheless whether the mTOR pathway is really dysregulated during muscle ageing is still unclear (24) . Furthermore, the significance of mTOR activation in longevity remains to be fully elucidated. In fact, mTOR/ S6K I downregulation is associated with reduced translation rate and the appearance of disuse atrophy (25, 26) and mTOR/p70S6K upregulation underlies exercise-and nutrient-induced change in muscle mass and fibers size (25) . On the contrary, caloric restriction, known to negatively impact on mTOR activity, is the most reproducible manner to extend life span in animal models.
Despite published data suggesting no change (7, 8, 21) or muscle specific increase (9) of mTOR and S6KI activation in aged in comparison with young skeletal muscle, the responsiveness of these signals to various stimuli is clearly impaired (7) (8) (9) (10) . In apparent contrast with other authors describing agerelated increase of mTOR/p70S6K basal activation in skeletal muscle of rodents (8) and humans (26), we found a significant reduction of the basal activation of both signals in the aged. These results disagree with previous observations by Kinnard et al. who found a significant decrease of total p70S6K and a concomitant increase of its phosphorylated form in elderly rats (30-36 months) compared to young (6 months) (27) . In our experimental conditions the activation level of signals appeared almost doubled in the adult compared to the aged and confirmed what was previously found by using the same assay procedure in vitro (23) . This evidence may be related to different age-related responsiveness of the pathway to the experimental conditions adopted or to different contribution of endogen insulin/IGFI to basal activation state of signals. In fact, in the assay isolated muscles were incubated for a total of 75 min of which the initial 45 min were finalized to endogen hormone removal before incubation with EAAem. Indeed, our observations may suggest a higher dependence of signal basal activation from endogen hormones in the aged compared to the young. Furthermore, as a wide spectrum of signal activation has been found in presence of several conditions (i.e. fed state, time-point of muscle biopsy) (28) , different susceptibility to experimental procedure might also be taken into consideration.
At the time-point considered no change of mTOR/p70S6K activation was observed in untreated adult muscles acutely exposed to EAAem, whereas a significant increase of p70S6K activation, unlike mTOR, was observed in the aged. This evidence agrees with previous observations of a delayed response of the signaling pathway to EAA in aged skeletal muscle (29) and highlights an earlier response of the pathway in the young with a wave of activation already finished at the end of the incubation procedure.
In chronically treated animals a different pattern of basal activation was found in both groups of age compared to untreated rats. In muscles from adults rats the basal level of p70S6K, unlike mTOR activation, appeared significantly lower, whereas an opposite pattern was observed in aged muscles. Importantly, the different pattern of activation of signals in untreated and treated muscles from aged rats may suggest a slowdown of activation due to chronic treatment.
In conclusion, the results of our study confirm the notion that mTOR/S6KI signaling is a fundamental target of EAA supplementation even in settings of prolonged administration, and, for the first time, identify a possible time change of the pattern of signal activation due to prolonged treatment in the aged. Considering that only one time-point following incubation with EAAem was analysed, the results from the present study are preliminary and worthy of future confirmation.
